Integrins as Novel Drug Targets for Overcoming Innate Drug Resistance
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
37-43
Author(s):
Jason S. Damiano
WT1 as a Novel Target Antigen for Cancer Immunotherapy
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
45-54
Author(s):
Y. Oka, A. Tsuboi, O. A. Elisseeva, K. Udaka and H. Sugiyama
Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
55-75
Author(s):
Angela casini, Andrea Scozzafava, Antonio Mastrolorenzo and Claudiu T. Supuran
Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents
Journal:
Current Cancer Drug Targets
Volume:
2
Page:
77-86
Author(s):
D. L. Crowe
The Impact of Thrombopoietin on Clinical Practice
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
369-377
Author(s):
Russell Basser
Application of Phage Display Technology to Cancer Research
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
29-43
Author(s):
Yum L. Yip and Robyn L. Ward
Porphyrins in Photodynamic Therapy - A Search for Ideal Photosensitizers
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
187-207
Author(s):
S. K. Pushpan, S. Venkatraman, V. G. Anand, J. Sankar, D. Parmeswaran, S. Ganesan and T. K. Chandrashekar
subject Index To Volume 1
Journal:
Current Molecular Medicine
Volume:
2
Page:
97-99
Author(s):
Science Publishers Bentham
Vitamin D and Vitamin D Analogs in Cancer Treatment
Journal:
Current Drug Targets
Volume:
3
Page:
85-94
Author(s):
G.J.C.M. van den Bemd and G.T.G. Chang
Contribution of Efflux Pump Activity to the Delivery of Pulmonary Therapeutics
Journal:
Current Drug Metabolism
Volume:
3
Page:
1-12
Author(s):
K. O. Hamilton, M. A. Yazdanian and K. L. Audus